SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2023

SIGNIFICANT ACCOUNTING POLICIES

Schedule of cash, cash equivalents, and restricted cash

	December 31,		December 31,		December 31,
	2023		2022		2021
Cash and cash equivalents	$	30,546	$	24,535	$	79,423
Restricted cash		—		—		5,100
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	$	30,546	$	24,535	$	84,523

Schedule of estimated useful lives of the assets

Computers and peripheral equipment	33%
Office furniture and equipment	6% to 20% (mainly 15%)
Leasehold improvements	Over the shorter of the term of the lease, or the useful life of the assets

Schedule of remaining performance obligations which are expected to be satisfied and recognized in future periods

	Year Ending December 31,
					2026 and
	2024		2025		thereafter
Products	$	227	$	2	$	—
Services		38,593		9,927		6,981
	$	38,820	$	9,929	$	6,981

Schedule of significant changes in the deferred revenue

	Year Ended December 31,
	2023		2022
Balance, at the beginning of the year	$	52,586	$	54,616
Revenue recognized		(17,469)		(38,625)
Increase in deferred revenues and customer advances		20,613		36,595
Balance, at the end of the year		55,730		52,586
Less current portion at the end of the year		(38,820)		(36,634)
Long-term portion at the end of the year	$	16,910	$	15,952

Schedule of components of AOCI

	Gains (losses)
	on AFS		Gains (losses)
	marketable		on cash flow
	securities		hedges		Total
Balance as of January 1, 2023	$	(6,376)	$	(4,577)	$	(10,953)
Other comprehensive loss before reclassifications, net of tax		2,859		(2,165)		481
Amounts reclassified from AOCI		(213)		6,567		6,567
Other comprehensive income, net of tax		2,646		4,402		7,048
Balance as of December 31, 2023	$	(3,730)	$	(175)	$	(3,905)

NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (Cont.)

	Year Ended December 31,
	2023		2022		2021
Amounts reclassified from AOCI
Cost of revenues	$	1,400	$	814	$	(513)
Research and development expenses, net		2,983		1,735		(990)
Selling and marketing expenses		1,217		708		(406)
General and administrative expenses		967		426		(229)
Total operating expenses (income), before income taxes	$	6,567	$	3,683	$	(2,138)

Schedule of weighted-average assumptions

	Year Ended December 31,
	2023	2022	2021
Dividend yield	1.13%	1.13%	0.88%
Expected volatility	46.24%	47.64%	49.45%
Risk-free interest	4.57%	2.83%	0.5%
Expected life	3.60 years	4.10 years	3.61 years

Schedule of share-based compensation expenses

	Year Ended December 31,
		2023		2022	2021
Cost of revenues	$	388	$	425	$	411
Research and development expenses, net		2,685		3,481		2,772
Selling and marketing expenses		4,297		6,032		6,170
General and administrative expenses		4,010		5,184		4,811
Total share-based compensation expenses	$	11,380	$	15,122	$	14,164